AGP Executive Report
Last update: 5 hours agoMedical Device & Transplant Care: Implantica’s Interim Report (Jan–Jun 2026) and Hansa Biopharma’s first commercial patient in Australia receiving a living-donor kidney transplant using Idefirix highlight ongoing momentum in transplant desensitisation and device pipelines. Reflux Treatment Update: RefluxStop® reports Q2 growth (net sales +66% to TEUR 717) and Nature Scientific Reports data on mid- to long-term safety in 602 patients, plus FDA PMA approval for a future U.S. launch. Public Health & Safety: Norway’s King Harald V is hospitalised for hemolytic anaemia complications after cortisone treatment led to fluid retention; he’s on sick leave with the Crown Prince acting as regent. Digital Health & Privacy: ChatGPT Ads is rolling out across 31 European markets including Liechtenstein, but only on Free and Go plans and without personalized ads in the EEA/Switzerland. Cybersecurity: A major France tax-data breach is being used for highly targeted impersonation scams, with regulators warning affected taxpayers. Local Care & Community: RJAH surgeons complete a 2,000-mile European road trip to raise funds for charities, including League of Friends at RJAH and Lila’s Legacy.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
